| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 18.41B | 24.58B | 18.81B | 18.84B | 16.66B | 19.59B |
| Gross Profit | 18.18B | 24.58B | 18.30B | 18.80B | 16.62B | 19.55B |
| EBITDA | 2.24B | 0.00 | 2.76B | 3.32B | 1.65B | 3.87B |
| Net Income | 1.20B | 4.39B | 1.56B | 1.93B | 758.00M | 2.53B |
Balance Sheet | ||||||
| Total Assets | 45.62B | 55.11B | 41.90B | 46.65B | 42.67B | 47.94B |
| Cash, Cash Equivalents and Short-Term Investments | 22.21B | 17.82B | 17.99B | 21.87B | 16.19B | 17.74B |
| Total Debt | 3.64B | 5.17B | 2.28B | 361.00M | 628.00M | 592.00M |
| Total Liabilities | 18.45B | 24.11B | 14.44B | 17.64B | 14.85B | 17.87B |
| Stockholders Equity | 27.17B | 31.00B | 27.46B | 29.01B | 27.82B | 30.06B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.34B | -573.00M | 3.40B | 1.32B | 1.65B |
| Operating Cash Flow | 0.00 | 5.38B | -524.00M | 3.79B | 1.61B | 2.09B |
| Investing Cash Flow | 0.00 | -2.24B | -296.00M | -524.00M | -320.00M | -169.00M |
| Financing Cash Flow | 0.00 | -1.32B | -3.04B | -1.14B | -2.82B | -1.38B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥60.80B | 10.05 | 17.21% | 4.27% | 11.13% | 20.95% | |
72 Outperform | ¥2.09T | 3.01 | 20.02% | 2.63% | 31.37% | 148.24% | |
70 Outperform | ¥41.53B | 10.52 | 6.18% | 4.42% | 30.88% | 193.36% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | ¥174.85B | 10.82 | 7.40% | 5.60% | 15.68% | 49.07% | |
63 Neutral | ¥16.44B | 8.91 | ― | 2.86% | 18.85% | 52.87% | |
53 Neutral | ¥24.37B | -8.03 | ― | ― | -45.54% | -286.03% |